211 related articles for article (PubMed ID: 18849119)
1. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
Magné N; Chargari C; Vicenzi L; Gillion N; Messai T; Magné J; Bonardel G; Haie-Meder C
Cancer Treat Rev; 2008 Dec; 34(8):671-81. PubMed ID: 18849119
[TBL] [Abstract][Full Text] [Related]
2. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
[TBL] [Abstract][Full Text] [Related]
3. Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.
Goyal BK; Singh H; Kapur K; Duggal BS; Jacob MJ
Int J Gynecol Cancer; 2010 Aug; 20(6):1041-5. PubMed ID: 20683414
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET in cervical cancer: staging, re-staging and follow-up.
Bjurberg M; Kjellén E; Ohlsson T; Ridderheim M; Brun E
Acta Obstet Gynecol Scand; 2007; 86(11):1385-91. PubMed ID: 17851810
[TBL] [Abstract][Full Text] [Related]
5. [Positron emission tomography in the management of cervix cancer patients].
Bonardel G; Chargari C; Gontier E; Bauduceau O; Soret M; Dechaud C; Fayolle M; Foehrenbach H
Cancer Radiother; 2009 Oct; 13(6-7):490-8. PubMed ID: 19699130
[TBL] [Abstract][Full Text] [Related]
6. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
Schwarz JK; Lin LL; Siegel BA; Miller TR; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1502-7. PubMed ID: 18538498
[TBL] [Abstract][Full Text] [Related]
7. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
8. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
9. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH
J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma.
Fleming S; Cooper RA; Swift SE; Thygesen HH; Chowdhury FU; Scarsbrook AF; Patel CN
Clin Radiol; 2014 Dec; 69(12):1235-43. PubMed ID: 25439186
[TBL] [Abstract][Full Text] [Related]
11. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
12. Effect of 18F-fluorodeoxyglucose positron emission tomography on the management of patients with head and neck squamous cell carcinoma.
Goyal P; Hsu JM; Kellman RM
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):694-9. PubMed ID: 19128678
[TBL] [Abstract][Full Text] [Related]
13. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
14. PET/CT imaging to guide cervical cancer therapy.
Grigsby PW
Future Oncol; 2009 Sep; 5(7):953-8. PubMed ID: 19792965
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Chung HH; Kim SK; Kim TH; Lee S; Kang KW; Kim JY; Park SY
Gynecol Oncol; 2006 Oct; 103(1):165-70. PubMed ID: 16574205
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of pretherapeutic 18F-FDG PET/CT in cancer of the uterine cervix: a retrospective study of 53 patients].
Chastan M; Manrique A; Baron M; Sanson AE; Diologent B; Vera P; Hitzel A
Gynecol Obstet Fertil; 2010 Apr; 38(4):244-9. PubMed ID: 20359931
[TBL] [Abstract][Full Text] [Related]
17. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
[TBL] [Abstract][Full Text] [Related]
18. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT for staging of penile cancer.
Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
[TBL] [Abstract][Full Text] [Related]
20. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
